Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
FDA completed the current phase of its substantive review of GraftAssureDx in late July 2026, requesting additional information but signaling progress toward authorization.
CoreWeave closed a $2.6 billion delayed draw term loan facility (DDTL 5.5 Facility) with a five-year maturity, backed by shorter-dated customer contracts averaging three years.
Nexxen execs to participate in three financial conferences: Canaccord Genuity Growth Conference (Aug 12), Rosenblatt Tech Summit (Aug 18), and Citi Global TMT Conference (Sep 8).
Enphase Energy's Board voted to retain director Benjamin Kortlang despite shareholder feedback, citing his expertise in technology roadmap and capital markets.
